Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
| Actual shortage: | 212 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2706 (92%) | |
Discontinuation Reports |
300 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 298 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
362 (11%) |
|
Overdue reports |
85 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT BORTEZOMIB | 3.5MG | POWDER FOR SOLUTION | Actual shortage | 2025-01-23 | 2025-01-23 | 248442 |
| ACT BORTEZOMIB | 3.5MG | POWDER FOR SOLUTION | Resolved | 2020-01-30 | 2020-05-29 | 104930 |
| TEVA-BUPRENORPHINE/NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-09-26 | 2020-01-24 | 94896 |
| TEVA-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2019-10-03 | 2020-01-24 | 95396 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-06-25 | 2021-04-29 | 118960 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-05-01 | 2020-05-08 | 113726 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-04 | 2019-10-10 | 68572 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-23 | 2020-05-08 | 113043 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-03 | 2020-05-08 | 110797 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-04 | 2019-11-22 | 68580 |
| TEVA-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-04 | 2019-10-17 | 68569 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-04 | 2020-02-13 | 68577 |
| ACT CABERGOLINE | 0.5MG | TABLET | Actual shortage | 2017-05-03 | 2017-10-05 | 8767 |
| ACT CELECOXIB | 200MG | CAPSULE | Actual shortage | 2021-02-18 | 2021-05-06 | 134357 |
| ACT CELECOXIB | 200MG | CAPSULE | Resolved | 2020-03-06 | 2020-09-03 | 107998 |
| ACT CELECOXIB | 200MG | CAPSULE | Resolved | 2021-01-22 | 2021-02-12 | 132291 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2017-03-17 | 2018-10-11 | 3390 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2021-01-28 | 2021-02-12 | 132669 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2019-08-22 | 2020-03-12 | 92235 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2019-08-22 | 2021-02-12 | 92232 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |
| TEVA-DICLOFENAC EC | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2025-03-20 | 2025-03-20 | 253156 |
| TEVA-DICLOFENAC EC | 25MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-01-25 | 2024-01-26 | 217254 |
| TEVA-DICLOFENAC EC | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2025-04-25 | 2025-04-25 | 255812 |
| TEVA-DICLOFENAC SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2025-04-29 | 2025-04-29 | 256131 |
| TEVA-DICLOFENAC-K | 50MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253168 |
| TEVA-DILTIAZEM CD | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81307 |
| TEVA-DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-06-04 | 2019-06-04 | 85572 |
| TEVA-DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-06-04 | 2019-06-04 | 85575 |
| TEVA-DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-10-25 | 2019-10-26 | 97232 |
| TEVA-DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-10-25 | 2019-10-26 | 97235 |
| TEVA-DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-10-25 | 2019-10-26 | 97238 |
| TEVA-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117491 |
| TEVA-DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117494 |
| TEVA-ECTOSONE | 0.1% | LOTION | Discontinued | 2023-12-05 | 2023-12-05 | 212526 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256134 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
| TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |